SCHEMBL6506874

SCHEMBL6506874

CN(C)C(=O)C1(N2CCCCC2)CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.46
USP2 O75604 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
EPHX1 P07099 1/20 0.41
EPHX2 P34913 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
ABL1 P00519 1/20 0.36
RIN1 Q13671 1/20 0.36
RECQL P46063 1/20 0.35
DDB1 Q16531 1/20 0.35
CRBN Q96SW2 1/20 0.35
GPR119 Q8TDV5 1/20 0.35
ALDH1A1 P00352 2/20 0.34
MAPT P10636 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
ATM Q13315 1/20 0.34
TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6511550 0.99 HPGD (0.43) HPGDUSP2SMN1; SMN2EPHX1EPHX2
SCHEMBL6510041 0.84 HPGD (0.49) HPGDUSP2SMN1; SMN2EPHX1EPHX2
SCHEMBL6531219 0.82 HPGD (0.47) HPGDUSP2SMN1; SMN2EPHX1EPHX2
SCHEMBL17848733 0.78 USP2 (0.47) HPGDUSP2SMN1; SMN2EPHX1EPHX2
SCHEMBL15491798 0.78 HPGD (0.51) HPGDUSP2SMN1; SMN2EPHX1EPHX2
SCHEMBL31479099 0.78 USP2 (0.49) HPGDUSP2SMN1; SMN2EPHX1EPHX2
SCHEMBL6505941 0.77 USP2 (0.46) HPGDUSP2SMN1; SMN2EPHX1EPHX2
SCHEMBL3327975 0.76 HPGD (0.49) HPGDUSP2SMN1; SMN2EPHX1EPHX2
SCHEMBL4610629 0.76 EPHX1 (0.48) HPGDUSP2SMN1; SMN2EPHX1EPHX2
SCHEMBL6508625 0.75 HPGD (0.49) HPGDUSP2SMN1; SMN2EPHX1EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005047253-A1 MELANOCORTIN RECEPTOR AGONISTS LG LIFE SCIENCES LTD. (KR) 2005-05-26 WO disclosed